While PPARγ activation was mostly reported to exhibit anticancer effects in a variety of cancer cells including melanoma35, we have recently characterized a protumorigenic paracrine role of the PPARγ agonist RGZ in human melanoma7,8. Here, PPARG is linked to cancer.